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SYMPATHETIC AND SENSORY INNERVATION AND ACTIVATION OF INGUINAL 
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by 
JENNIFER MENDEZ 
Under the Direction of Aaron Roseberry, PhD 
 
ABSTRACT 
 Studies have suggested the possibility that there is sensory (SS) afferent signaling 
from white adipose tissue (WAT) to the brain, which may play an important role in 
communication with the brain sympathetic nervous system (SNS) outflow to WAT. Therefore, 
we tested whether the SNS-SS feedback loop between the subcutaneous inguinal WAT (IWAT) 
and the epididymal WAT (EWAT) exists. These fat pads were chosen due to 1) their divergent 
role in manifestation of metabolic disorders with the IWAT being beneficial and the EWAT 
being detrimental, as well as 2) different lipolytic response to glucoprivic 2-deoxyglucose 
(2DG). By using retrograde tract tracers Fast Blue (FB) and Fluorogold (FG), we found that the 
IWAT is more innervated than EWAT by both the SS and SNS ganglia (T13-L3). Surprisingly, 
we found ~12-17% of double-labeled cells in the SNS and SS ganglia innervating fat depots, 
implying SNS-SS crosstalk loops between the IWAT and EWAT. Increased neuronal activation 
by 2DG was observed in the SNS ganglia to both IWAT and EWAT but not in the SS dorsal root 
ganglia. In addition, 2DG induced lipolysis in both fat pads with greater lipolytic properties in 
the IWAT as a result of higher density of the SNS-SS fibers. Collectively, our results show 
neuroanatomical reality of the IWAT and EWAT SNS-SS neural crosstalk with a coordinated 
control of lipolytic function. 
INDEX WORDS: Lipolysis, 2-deoxyglucose, c-Fos, Fast Blue, Fluorogold, Dorsal root ganglia 
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1 INTRODUCTION  
1.1 Background    
Today, approximately 30% of the world’s population are either obese or overweight and 
the number has doubled since 1980 (24). In 2012, in the U.S. alone, more than one third of the 
population were considered obese (26). Obesity is the cause a variety of secondary health 
consequences such as cardiovascular disease, type II diabetes, stroke, hypertension (17, 27, 28, 
40). Along with these health consequences come an economic burden. In 2008, the U.S medical 
costs associated with this disease was estimated to be $147 billion dollars(15). Obesity can result 
from a variety of factors including genetics and behavior. Most commonly it is due to excess 
energy being consumed compared to that which is being expended. In mammals, the majority of 
surplus energy is being stored in the form of triacylglycerols (TAGs) in various WAT depots 
which are located subcutaneously, around the upper and lower body regions and abdomen, as 
well as internally around vital organs.  
1.2 Lipolysis induced by the SNS 
During times of increased energy demands lipid mobilization occurs. The sufficiency of 
the activation of the sympathetic nervous system (SNS) innervation of WAT for lipid 
mobilization was demonstrated in ex vivo studies with electrical stimulation of the intact SNS 
nerves innervating EWAT which resulted in increased concentration of free fatty acids in the 
incubation medium (13). In addition, it was demonstrated that the removal of the sole source of 
circulating epinephrine by bilateral demedullation fails to block lipolysis (2, 14) whereas the 
SNS innervation of WAT is sufficient and necessary for the beginning of lipolysis. The SNS 
postganglionic nerves release norepinephrine (NE) which binds to beta adrenergic receptors (β-
AR), which further activates a cascade of intercellular signaling events initiating lipolysis, thus 
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the SNS is the principal initiator for lipolysis and the balance between the stimulation of lipolysis 
by β-ARs and its inhibition by α2-AR imposes the degree of lipolysis(12, 18). When NE binds to 
β3-ARs it activates the G coupled GTP binding protein GS. This activation increases cAMP by 
activating adenylyl cyclase and results in stimulation of protein kinase A (PKA) which 
phosphorylates two key players in lipolysis, hormone sensitive lipase (HSL) and perilipin A (1, 
11, 19), an adipocyte bound protein that prevents hydrolysis of the stored fat. When perilipin A 
is phosphorylated, it acts as a scaffolding protein exposing the lipid droplet for the translocation 
of HSL (30) from the cytoplasm to the cell wall, to facilitate in lipolysis to undergo hydrolysis of 
triacylglycerol to result in free fatty acids (FFAs) and glycerol. There are two rate-limiting 
enzymes considered for lipolysis, which have different intracellular cascades for the hydrolysis 
of TAG. For stimulated lipolysis (i.e., SNS/NE-stimulated) pHSL is the rate-limiting enzyme 
whereas under basal lipolysis (i.e., non-SNS/NE-stimulated) ATGL is the rate-limiting enzyme. 
During stimulated lipolysis ATGL assists in hydrolysis of TAG by removing, a FA to produce 
diacylgylercol (DAG), which frees another FA by pHSL to produce monoacylglycerol (MAG), 
where the last FA is removed by MAG lipase. 
 
1.3  SNS Innervation of WAT 
 
The mobilization of WAT is not homogenous, lipolysis occurs at different lipolytic rates, 
depending primarily on where the adipose tissue is located. We observed this while studying the 
reversal of a naturally-occurring seasonal obesity in Siberian hamsters where obesity (body fat of 
~50%) induced by long summer days is reversed when exposed to short “winter-like” days (body 
fat of ~20%) (5, 8, 22, 37). Internal WAT pads [e.g., retroperitoneal WAT (RWAT), and 
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epididymal WAT (EWAT)] are mobilized at a higher degree compared to the externally located 
subcutaneous WAT [e.g., dorsosubcutaneous WAT (DWAT), and inguinal WAT (IWAT) (3, 6, 
7). The SNS innervation of WAT was demonstrated histologically, with innervation of the SNS 
marker tyrosin hydroxylase (TH) immunoreactivity (-ir) (33). Direct evidence of the SNS 
innervation was observed in the postganglionic SNS ganglia by the monosynatpic retrograde 
tract tracer, Fluorogold (FG), both intra-IWAT and intra-EWAT(38). Functionally, selective 
surgical and chemical SNS denervation of WAT completely blocks lipolysis emphasizing the 
master role of the SNS innervation in triggering lipolytic responses (4, 39). Using a retrograde 
viral tract tracer, pseudorabies (PRV), we previously identified the central origins of the SNS 
outflow to WAT by, in Siberian hamsters (2, 34, 35) and Sprague-Dawley rats (2). This has 
further been investigated in various fat pads including IWAT, EWAT, RWAT, and MWAT (4, 9, 
25, 29, 31). Collectively, our viral studies revealed a number of the central sites implicated in the 
SNS efferent outflow to above-mentioned fat pads as well as sensory system (SS) afferent inflow 
from those fat pads to the brain (2, 29). Importantly, many areas contained both PRV152 and 
H129 (SNS + SS colocalization) viruses suggesting long SNS-SS feedback circuits (2, 9, 29). 
Notably, some areas exhibited greater levels of infection indicating SNS drive from the brain to 
WAT is fat pad-specific. In concordance with this, we later confirmed differential SNS drives to 
WAT by measuring NE turnover (NETO) levels in Siberian hamsters in response to various 
metabolic stimuli (10) (i.e., cold exposure, food deprivation, glucoprivation, and central 
stimulation with melanocortins). 
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1.4 SS Innervation of WAT 
Histologically, two proven sensory neuropeptides, substance P and calcitonin gene-
related peptide (CGRP), was found in the WAT of Sprague Dawley rats while CGRP was found 
in the IWAT and EWAT of the Siberian hamster, inferring WAT innervation by the SS (32, 33). 
However, direct evidence of the SS innervation of WAT was first observed after injecting the 
retrograde tract tracer, True Blue, into the IWAT and DWAT of laboratory rats which resulted in 
labeling of pseudounipolar neurons in DRG associated with the concrete fat depot (16). 
Recently, more focus has been on understanding the SS role in WAT brain communication. 
Using the same conventional tract tracer and viral methodology, we revealed the central SS 
circuits from WAT of not only Siberian hamsters, but of Sprague-Dawley rats as well (16, 23, 
29). There is strong evidence suggesting that neural feedback loops may exist between WAT SS 
afferents from and the SNS efferents to WAT. This was demonstrated by identifying the SS 
innervation from WAT to the brain that shared many identical sites across the neuroaxis with the 
neurons sending the SNS outflow to WAT (25, 29, 36). Studies involving excitatory effect of 
adipokine leptin on the SS afferents emanating from WAT, support the suggestion that leptin 
plays a novel role as a SS paracrine factor in WAT by informing the brain of lipid stores in WAT 
and does so in a fat pad-specific manner (23). It is also suggested that lipolysis within WAT may 
activate the SS afferent signaling. In support of the latter, intraperitoneal (i.p.) injections of 2-
deoxyglucose (2DG) a non-metabolizable glucose analog, and intra-WAT injections CL, a beta-
adrenergic agonist, rapidly increase neurophysiological spike activity in WAT SS fibers (36). In 
this regard, surgical removal or the SS denervation of one fat depot followed by compensatory 
increase in fat mass across the remaining fat depots emphasizes the importance of the SS 
signaling (20, 32).  
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1.5 Purpose of experiment 
Because it is known that IWAT and EWAT respond to lipolytic stimuli differently and 
are located differently in the hamsters, these two are a good model to study activation of the SS 
and SNS innervation of WAT. In our previous studies, the use of Fast Blue (FB) and Fluorogold 
(FG) tract tracing enabled us to identify mostly separate SNS innervation within the IWAT and 
EWAT. Here, we hypothesize that IWAT as well as EWAT both will share SS and SNS 
innervation. When given the lipolytic stimuli, 2DG, IWAT has a higher SNS drive compared to 
that of EWAT (10), implying that the first should have a higher SNS neuronal activation and as a 
result, a higher lipolytic rate. Additionally, given that the SS afferent signaling from WAT to the 
brain may inform the brain of lipid stores within WAT (23), we hypothesize that the greater SNS 
drive to IWAT might result in greater SS feedback.  
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2     MATERIALS AND METHODS 
All procedures were approved by the Georgia State University Institutional Animal Care and 
Use Committee and are in concordance with Public Health Service and United States 
Department of Agriculture guidelines.  
 
2.1 Animal Model 
Adult male Siberian hamsters, (Phodopus sungorus, ~3-4 mo old) were single-housed 
after being selected from our breeding colony. Animals were kept in a long day photoperiod 
(16:8-h light-dark cycle) at 21 ± 2 °C, with relative humidity at 50 ± 10%) with ad libitum access 
to water and rodent chow. Hamsters were single-housed for 7–10 days before all procedures. 
 
2.2 SNS and SS innervation of WAT 
 Siberian hamsters (n = 36) were anesthetized with 2% isoflurane. The skin around the 
haunch area over the IWAT pad was shaved and wiped with 70% ethanol and then 10% 
povidone iodine solution (Ricca Chemical, Arlington, TX) repeatedly, finishing with povidone 
iodine. An incision was made around this haunch to expose the IWAT. Similarly, we made an 
incision in the peritoneal wall close to the EWAT to expose the fat pad for injections. Once 
exposed, fat pads were maintained moist for the entire procedure. The two tract tracers, 2% FG 
(Fluorochrome, Denver, CO) and 1% FB (EMS-CHEMIE GmbH, Gross-Umstadt) were injected 
unilaterally into eight separate sites across the IWAT pad (1 μl per locus for a total of 8 μl) and 
into six separate sites across the EWAT pad (1 μl per locus totaling 6 μl). After each injection, 
the needle was held in place for 1 min to minimize reflux up the outside of the needle. The 
peritoneal wall was closed with sterile sutures and the skin incision was closed with sterile 
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wound clips. In order to minimize the risk of bacterial infection nitrofurozone (nz Puffer; Hess & 
Clark) was applied locally on the incision. To ensure proper labeling, tracers were switched 
between each group to account for differential labeling between tracers. Two weeks post 
injections of tracers hamsters were perfused for histological analyses as described below. 
 
2.3 SNS and SS activation of WAT 
Hamsters (n=36) were divided into three groups based on an average body weight of ~40 g. 
On the day of the procedure, animals were transferred to the experimental room and were 
allowed to acclimate for at least 2 h to reduce any stress associated with the transfer. After 
acclimation, animals were depouched and food deprived. Two hours later the animals were given 
the appropriate treatment of i.p. injections of saline or 2-DG (500 mg/kg or 1000 mg/kg). The 2 
hour period post depouching was performed to minimize any disruption in sympathetic activity 
due to the depouching.  
2.4 Histological preparation and harvesting of ganglia 
Hamsters were overdosed with pentobarbital sodium (300 mg/kg ip) and perfused 
transcardially with heparinized (0.9%) saline and paraformaldehyde (4%) in 0.1 M phosphate 
buffer (pH 7.4). DRG and the SNS ganglia associated with spinal vertebrae T12-L3 were 
carefully removed and debrided from the epineurium, post fixed in the same fixative for 20 min, 
and then transferred to a sucrose solution (18%) with 0.1% sodium azide where it was stored at 4 
°C for 2 d. The ganglia were sectioned longitudinally at 20 μm on a freezing stage cryostat and 
collected onto gel-coated slides (Superfrost Plus, VWR International, West Chester, PA) in a 
series of three (with every forth section on the same slide), immediately after being sliced   and 
stored at 4 °C until processing for immunohistochemistry (IHC). 
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2.5 c-Fos and Fluorogold IHC 
The ganglia sections were rinsed in PBS (3 ×10 min), followed by a 1 h incubation in 5% 
normal horse serum (NHS) (1:200; Vector Laboratories, Burlingame, CA) in PBTx (PBS 
containing 0.3% Triton X-100). Sections were then incubated in primary rabbit anti-c-Fos (1:500 
for DRG and 1:2000 for SNS ganglia; sc-52; Santa Cruz Biotech, Santa Cruz, CA) antibody with 
10% NHS in PBTx with 0.3% sodium azide for 2 d at 4 °C. Next, the sections were rinsed with 
PBS (3×15 min), then incubated for 3 h in Alexa 594 conjugated streptavidin anti rabbit (1:400; 
Molecular Probes, Eugene, OR) with 10% NHS in PBTx with at 4 °C. For IHC controls, the 
primary antibody was either omitted or reabsorbed with the immunizing peptide overnight at 4 
°C thus resulting in negative immunostaining (data not shown). Following subsequent rinses 
with PBS (4×15 min), the sections were incubated in another primary rabbit anti Fluorogold 
(1:20,000; Fluorochrome, Denver, CO) antibody followed by the secondary Alexa 488 
conjugated streptavidin anti rabbit (1:400; Molecular Probes, Eugene, OR) antibody. Sections 
were cover slipped using ProLong Gold Antifade Reagent (Molecular Probes) for future analysis 
and quantification. 
 
2.6 Western blot analysis  
 For the western blot experiment, IWAT and EWAT were immediately excised from 
animals after injection with pentobarbital sodium (300 mg/kg) prior to perfusion. Tissues were 
then snap frozen with liquid nitrogen and stored at -80 °C until processed. The fat pads were then 
minced and placed in a microcentrifuge tube containing  zirconium oxide beads and a 2:1 ratio of  
Homogenization buffer [50 mM HEPES, 100 mM NaCl, 10 % SDS, 2 mM EDTA, 0.5 mM 
DTT, 1 mM benzamidine] and both protease inhibitor cocktail (Calbiochem, EMD Chemicals, 
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Gibbstown, NJ), and phosphatase inhibitor cocktail (Thermo Fischer Scientific, Rockford, IL).  
Tubes were inserted into the bullet blender for 2 x 1 min to break down the tissue and then 
centrifuged for 10 min at 13,000xg. The supernatant was then collected and extra aliquots were 
stored in -80 °C for future use. Protein concentration for each sample was determined by 
bicinchoninic acid protein assay kit (Thermo Fisher Scientific, Rockford, IL) and used to 
determine the amount of 4X Loading buffer and Millipore water to add to 10 μg of protein 
sample for SDS processing. The samples were then heated at 95 °C for 5 min, loaded on to a 
low-bis SDS-PAGE [10.0 %:0.08 % acrylamide:bis] and then underwent electrophoresis. The gel 
was then transferred to PVDF membranes for immunoblotting. Once immunoblotting was 
completed each membrane was cut in the designated area so that we could stain for the specific 
protein (pHSL, HSL, and the beta actin). Membranes were washed 2x10 min in Tris-buffered 
saline (TBS), blocked for 2 h in a in a blocking solution (4% nonfat dry milk in TBS), then 
incubated for 48 h in a primary antibody of either HSL, pHSL and β-actin (each 1:1000; Cell 
Signaling Technology, Danvers, MA) at 4 °C. After primary antibody incubation membranes 
were washed 3x5 min with TTBS, then incubated in secondary goat anti-rabbit IgG HRP-linked 
antibody, 1:1000; Cell Signaling Technology, Danvers, MA) for 2 h at 4 °C. The membranes 
were rinsed 3x10 min in TBST and then incubated with LumiGLO chemiluminescent kit (Cell 
Signaling Technology, Danvers, MA) to visualize bands on a gel imager. 
2.7 Quantitative and statistical analysis 
The intensity of Western blot bands was quantified based on optical densitometry 
measurements using ImageJ (US National Institutes of Health, Bethesda, MA). Ratio values of 
proteins and the controls, pHSL/actin and HSL/actin, were collected and then used for the ratio 
of total pHSL/HSL.  
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Images were view and captured under 100X and 200X magnification with the Olympus 
BX41 microscope and the appropriate filters for FB, Alexa 594, and Alexa 488. FB, FG, and c-
Fos-ir neurons were considered positive based on cell size, shape, and fluorescent intensity. The 
acquired images were adjusted by contrast, brightness, sharpness, and overlaying of double-
labeled neurons by Adobe 250 Photoshop CS5 (Adobe Systems, San Jose, CA, USA). 
All statistical analysis were carried out using NCSS (version 2007, Kaysville, UT).  Data 
were analyzed by one-way repeated measures analysis of variance (ANOVA) followed by the 
post-hoc Bonferroni’s and Holm-Sidak’s tests using. Statistical significance was set at P<0.05 
and all values are presented as mean ±standard error of the mean. 
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3     RESULTS 
3.1 SS Innervation and Activation of WAT 
The dual microinjections of the conventional tract tracers FG and FB intra-IWAT and 
intra-EWAT appeared at the T12-L3 DRG (Fig. 2). Total numbers of single-labeled as well as 
double-labeled cells in the DRG innervating fat pads, were given as an absolute numbers and 
their total percentages (Fig 2A, B). The DRG exhibited a differential pattern of innervation from 
both fat pads with the most innervation coming from the lumbar L1-L3 (Fig 2B). The number of 
DRG single labeled neurons innervating IWAT was significantly greater as compared with that 
innervating EWAT at T13-L3 (P<0.05; Fig. 2B) with ~2-fold (P<0.05; Fig. 2C). In addition, the 
percentages of single labeled neurons were significantly greater in DRG associated with the 
IWAT as compared with EWAT at T12-L3 (P<0.05; Fig. 2A). Notably, the percentile number of 
double-labeled cells innervating both fad pads, was ~12-17% for each SS ganglia (Fig 2B). 
The number of c-Fos-ir cells in FG (from EWAT) and FB (from IWAT) labeled neurons 
were distributed across T12-L3 DRG (Fig. 3). Both doses of 2DG used in the study failed to 
induce neuronal activation in the DRG innervating the IWAT except for the L3 ganglion where 
2DG at 500 mg/kg tended to significantly increase the percentile number of neurons compared 
with the saline group (p=0.059; Fig. 3A). Notably, the percentile number of activated neurons, as 
indicated by c-Fos immunostaining related to the highest 2DG dose (1000 mg/kg), was markedly 
lower as compared to the lower dosage (p<0.05; Fig. 3A).  Similarly, there were no significant 
alterations in the numbers of c-Fos-ir cells innervating the EWAT for the only exception of L1 
DRG where both doses of 2DG significantly decreased c-Fos-ir in comparison with that in the 
saline group (p<0.05; Fig. 3B). 
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3.2 SNS Innervation and Activation of WAT 
The dual microinjections of the conventional tract tracers FG and FB intra-IWAT and 
intra-EWAT appeared at the T12-L3 SNS ganglia (Fig. 5). Total numbers of single-labeled as 
well as double-labeled cells in the SNS ganglia innervating fat pads, were given as an absolute 
numbers and their total percentages (Fig 5A, B). The SNS exhibited a differential pattern of 
innervation from both fat pads with the most innervation coming from the lumbar T13-L2 (Fig 
5B). The number single labeled neurons in the SNS ganglia  innervating IWAT were 
significantly greater as compared with that innervating EWAT at L1-L2 (P<0.05; Fig. 5B) with 
~2-fold (P<0.05; Fig. 5C). ). In addition, the percentages of single labeled neurons were 
significantly greater in DRG associated with the IWAT as compared with EWAT at T12-L3 
(P<0.05; Fig. 5A). In addition, the percentile number of double-labeled cells innervating both fad 
pads was ~12-16% for each SNS ganglia (Fig 5B). 
The number of c-Fos-ir cells in FG (from EWAT) and FB (from IWAT) labeled neurons 
were distributed across T12-L3 DRG (Fig. 6).  2DG induced a dose response increase of 
activation in the SNS to IWAT in ganglia T13 (p < 0.05, Fig 6A). Additionally, in IWAT, both 
dosages of 2DG (500 mg/kg and 1000 mg/kg) had a significant increase in SNS activation 
compared to the control group in SNS ganglia L1 (p < 0.05, Fig 6A). EWAT exhibited a 
significant increase in SNS activation in both T13 and L1 in the high dose of 2DG compared to 
the saline group as well as in T13 compared with the low dose of 2DG (p < 0.05, Fig 6B). 2DG 
at1000 mg/kg, but not at 500 mg/kg, significantly increased c-Fos-ir in double labeled cells at 
T13 SNS ganglion  in comparison with the control group (p < 0.05, Fig 6C).  
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3.3 Effect of 2DG on Lypolytic Activity in the WAT 
To ensure that 2DG was metabolizing in the animals accordingly we measured the blood 
glucose levels (Fig 7). Both doses of 2DG (500 mg/kg and 1000 mg/kg) significantly increased 
blood glucose levels in a dose-dependent manner with the highest increase by the latter dose 
(p<0.05; Fig. 7). Both IWAT and EWAT exhibited a dose-dependent significant increase in 
lipolysis indicated by the pHSL/HSL ratios compared with the saline group and this increase was 
significantly greater in the IWAT  in comparison to EWAT for each treatment doses of 2DG  
(p<0.05; Fig. 8D). There were no significant change in lipolysis following the saline treatment 
(p<0.05; Fig. 8D). The percent values of pHSL/HSL  had the same pattern; that is, 2DG dose-
dependently and markedly increased lipolysis in the WAT with the higher increase in the IWAT 
(p<0.05; Fig 8C). In addition, Saline administration did not have any effect on lipolysis in both 
fat depots (Fig. 8C).   
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Figure 1: Representative picture of Innervation and Activation of DRG to WAT.  
Photomicrograph illustrating labeling Sensory ganglia (DRG) L1 at 200X. Labeling of DRG 
after tract tracer injections in IWAT (blue) and EWAT (green). 2DG induced activation of DRG 
neurons a-d: Saline group, e-h: 2-DG 500mg/kg, i-l: 2-DG 1000 mg/kg. Scale bars = 50 μm. 
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Figure 2:  Distribution of SS Innervation of DRG to WAT.  
Distribution of IWAT and EWAT labeled cells in the DRG at the vertebral level T13-L3. A: Total 
percent of IWAT and EWAT.  B: Total neuronal number of IWAT and EWAT. C: Quantification 
of percent total labeled SS innervated neurons to IWAT and EWAT. *P<0.05 vs IWAT, #P<0.05 
vs EWAT. 
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Figure 3: Distribution of SS Activation of DRG to WAT.  
2DG induced activation of DRG neurons innervating WAT at the vertebral level T13-L3. A: 
Percent of c-Fos-ir positive neurons innervating IWAT. B: Percent of c-Fos-ir positive neurons 
innervating EWAT C: Percent of c-Fos-ir positive neurons innervating IWAT+IWAT DB labeled 
cells*P<0.05 vs Saline, #P<0.05 vs 500mg/kg 2DG. 
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Figure 4: Representative picture of Innervation and Activation of Sympathetic Ganglia to     
WAT. 
Photomicrograph illustrating labeling sympathetic ganglia (DRG) T13 at 200X. Labeling of 
sympathetic ganglia after tract tracer injections in IWAT (blue) and EWAT (green). 2DG 
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induced activation of sympathetic ganglia. a-d: Saline group, e-h: 2-DG 500mg/kg, i-l: 2-DG 
1000 mg/kg. Scale bars = 50 μm. 
 
 
 
 
                                 
 
Figure 5: Distribution of SNS Innervation of Sympathetic Ganglia to WAT.  
Distribution of IWAT and EWAT labeled cells in the SNS ganglia at the vertebral level T13-L3. 
A: Total percent of IWAT and EWAT.  B: Total neuronal number of IWAT and EWAT. C: 
Quantification of percent total SNS labeled neurons to IWAT and EWAT. *P<0.05 vs IWAT, 
#P<0.05 vs EWAT. 
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Figure 6: Distribution of SNS Activation of Sympathetic Ganglia to WAT. 
2DG induced activation of SNS neurons innervating WAT at the vertebral level T13-L3. A: 
Percent of c-Fos-ir positive neurons innervating IWAT. B: Percent of c-Fos-ir positive neurons 
innervating EWAT C: Percent of c-Fos-ir positive neurons innervating IWAT+IWAT DB labeled 
cells*P<0.05 vs Saline, #P<0.05 vs 500mg/kg 2DG. 
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Figure 7: Plasma Glucose.  
Plasma glucose from hamsters given i.p injections of 500 mg/ kg and 1000 mg/kg 2DG and 
saline vehicle. *P<0.05 vs Saline, #P<0.05 vs 500mg/kg. 
 
 
 
 
Figure 8: Western blot analysis of WAT. 
Western blot analysis of HSL and pHSL in IWAT and EWAT with 2DG treatment A. Immunoblot 
of pHSL, HSL, and beta-actin protein bands in IWAT. B Immunoblot of pHSL, HSL, and beta-
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actin protein bands in EWAT. C: Western blot with ratio of HSL/pHSL taken as percent of saline. 
D: Western blot with ratio of HSL/pHSL taken as ratio *P<0.05 vs Saline, #P<0.05 vs 
500mg/kg. 
 
4 DISCUSSION 
Collectively, using two distinct monosynaptic retrograde tract tracers, FG and FB, we for 
the first time revealed separate and shared innervation of both IWAT and EWAT of Siberian 
hamsters by the SNS and SS ganglia. Our results suggest that IWAT is more innervated than 
EWAT by both the SS and SNS. We also showed that 2DG dose-dependently increased the SNS 
drive to the WAT up to two hours with faded activation in the SS ganglia, implying the initial SS 
role in sensing the SNS drive. The higher innervation of the IWAT resulted in higher SNS drive 
and, thus, lipolytic rate within the IWAT compared with the EWAT, which support the notion of 
faster fat mobilization in the subcutaneous over inner fat depots. 
In agreement with the innervation study of IWAT and EWAT (38), we showed similar 
separate patterns of innervation by the SNS ganglia. Our tracing studies indicated more 
innervation of IWAT at T13 and L1 ganglia in concordance with the above-mentioned study; 
however, we did not confirm higher EWAT innervation emanating from L2 or L3 ganglia. Our 
results showed that both the total number and percentage of innervation SNS innervation to 
IWAT was greater for each ganglia analyzed. The dissimilarities between the two studies could 
arise from the difference in the amount of tracer injected in which IWAT was treated (5 μl 
previously vs 8 μl in the current study). The SS innervation of the IWAT and EWAT were 
similar to that of the SNS innervation of the IWAT being most innervated in all the ganglia in 
comparison to the EWAT. Our results demonstrated, that the IWAT appeared to be ~2-fold more 
innervated as compared with the EWAT by both the SS and SNS. Interestingly, we found that 
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both the SNS and SS ganglia contained roughly equal number of doubly labeled neurons (~12-
17%) showing neuroanatomical evidence of crosstalk between two fat depots.  
We previously showed that 2DG rapidly activates sensory afferents within 5-10 minutes 
(36) indicating that sensory afferents could sense some aspects of lipolysis. In this study, we 
observed increased SNS activation up to two hours after 2DG administration but not in the SS. 
Activation in the SNS peaks at two hours post systemic 2DG (21); however, this may not be 
optimal for the SS if they are primarily activated. At two hours, the activation of the SS 
affertents of WAT may have exhibited diminished effects. The SNS drive to the WAT is not 
uniform and, previously, we found that 2DG differently affects lipolysis in different fat depots 
(10).That is, NETO/lipolysis increases responding to 2DG treatment occur specifically in the 
IWAT but not in the EWAT when we used 2DG at 500 mg/kg (10). Nevertheless, in the current 
study we demonstrated that the higher 2DG dose (1000 mg/kg) is capable to trigger lipolysis. 
Therefore, we conclude that the EWAT may possess a higher threshold to 2DG in order 
to initiate lipolysis. In addition to establishing SNS activation we measured the lipolytic 
properties within both IWAT and EWAT by examining the ratio of pHSL and HSL, in vivo 
markers of lipolysis, for each fat pad after 2DG. We showed a significant dose-dependent 
increase of lipolysis in both the IWAT and EWAT in response to 2DG stimulus. Increases in the 
SNS activation to both IWAT and EWAT were exhibited specifically in T13 and L1 ganglia. The 
lipolytic rate in the IWAT was approximately two times greater than in the EWAT for both 2DG 
treatment groups.  It appears that more adipocytes from IWAT-SNS and SS innervation 
contributed to higher lipolytic response, thus supporting the notion of trivial dichotomic 
distinctions between the faster mobilized subcutaneous WAT and slower mobilized visceral 
WAT. 
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Collectively, our results show persuasive evidence of the IWAT and EWAT SNS-SS 
neural crosstalk with a coordinated control of lipolytic function. Additionally, we demonstrated 
that the IWAT appeared to be profoundly more innervated by either the SNS or the SS, thus, 
indicating higher lipolityc capacities of the subcutaneous WAT in response to 2DG. Finally, our 
tracing studies combined with the c-Fos immunostaining revealed specific ganglia contributing 
to the innervation of both fat depots, therefore, providing a model system with which to 
determine the lipolytic properties of distinct fat pad in response to various metabolic stimuli, 
such as glucoprivation, cold exposure and starvation. It is our hope that further understanding of 
the SNS-SS interaction in relation with WAT innervations could shed light on the intrinsic nature 
of WAT to maximize fat mobilization to reverse obesity and associated metabolic diseases. 
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